About two months after former Spectranetics CEO Scott Drake became executive board chair at Cordis, he’s moved into the corner office at the cardiology and endovascular devices company. Drake replaces Shar Matin, who has stepped down as CEO, the company announced yesterday. Hunter Philbrick, Hellman & Friedman partner and company board member, noted in a […]
Cordis
Cordis applauds Medicare expansion for carotid stenting
Cordis announced today that it supports a new expanded coverage decision from the Centers for Medicare & Medicaid Services (CMS). The expanded CMS coverage widens access to minimally invasive endovascular carotid therapy for patients with carotid artery disease. Cordis develops the Precise Pro Rx carotid stent system for this therapy. In a news release, the […]
Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B
MedAlliance announced today that Cordis acquired it for a total consideration that could reach up to $1.135 billion. The companies initially announced the planned deal in October of last year. Cordis, which develops interventional cardiovascular and endovascular technologies, made a $35 million investment last year. Its upfront closing payment totals $200 million, with achievement milestones […]
Cordis names former Spectranetics CEO as executive chair
Interventional vascular tech company Cordis today announced that board member Scott Drake will be the new executive chair of its board of directors. Drake succeeds Duke Rohlen, who served as executive chair since Hellman & Friedman and KKR acquired the company from Cardinal Health in 2021. Rohlen will stay on the company’s board of directors […]
The top 10 cardiac device stories of 2022
From pulsed-field ablation to noninvasive monitoring, this was an exciting year for cardiac device tech. Here are the top 10 cardiac device stories from MassDevice and its sister sites: 10. Medtronic to pay Acutus $17M following EU MDR submission of left-heart access portfolio Earlier this year, Acutus agreed to sell its left-heart access portfolio to […]
Cordis names Alan Tsai as GM of Greater China region
Cordis today announced it appointed Alan Tsai as general manager of its Greater China region. Tsai will head the leadership team that is responsible for strategic planning, business operation and team development in the Greater China region. He will be based in Shanghai and report directly to Bryan Loo, President of Cordis Asia Pacific. Tsai […]
Cordis to acquire MedAlliance for initial $235M
Cordis this week announced it will acquire MedAlliance for a total consideration of over $1 billion. Through the deal, Cordis will pay an initial investment of $35 million and an upfront closing payment of $200 million. In addition, it will pay regulatory achievement milestones of up to $125 million. Plus, commercial milestone payments could reach […]
Cordis begins enrollment in study of lesion treatment
Cordis announced that it began the Radiancy pre-market clinical study of its vascular stent system for treating lesions. Miami Lakes, Florida-based Cordis’ prospective, multi-center, single-arm study in Europe will assess the safety and efficacy of the SMART Radianz vascular stent system for the treatment of lesions in the iliac, superficial femoral or proximal popliteal arteries […]
Cordis among those investing $15M in Endovascular Engineering
Endovascular Engineering today announced the closing of a $15 million Series A1 financing co-led by Santé Ventures and Cordis. The Menlo Park, California–based startup is also called E2. It’s focused on developing advanced mechanical thrombectomy technology. Get the full story on our sister site Medical Tubing + Extrusion.
InnovHeart appoints former J&J executive as CEO
InnovHeart this week announced that it appointed medtech veteran David Wilson as CEO. Wilson has more than 30 years of experience in medical device industry. He previously served in numerous leadership roles at Johnson & Johnson, including worldwide president of Cordis. Wilson has also served at J&J as president of Mentor, VP of Ethicon R&D […]
Cordis names new CFO
Cordis today announced that it has appointed Christopher Scully as chief financial officer. Scully will lead the interventional cardiovascular technology company’s financial and IT functions to accelerate Cordis’s growth. Before joining the company, Scully was executive VP and CFO for PPD. He played a role in the company’s IPO and its eventual sale to Thermo […]